Corporate News     08-Jul-24
One 97 Communications allots 2.81 lakh equity shares under ESOS
One 97 Communications has allotted 2,81,394 equity shares under ESOS on 07 July 2024.

Consequent to aforesaid allotment, the issued, subscribed and paid-up equity share capital of the Company stand increased from Rs 635,992,696 (consisting of 635,992,696 equity shares of face value of Re 1 each) to Rs 636,274,090 (consisting of 636,274,090 equity shares of face value of Re 1 each)

Previous News
  One 97 Communications reports consolidated net loss of Rs 208.30 crore in the December 2024 quarter
 ( Results - Announcements 20-Jan-25   11:45 )
  Paytm partners with Greater Hyderabad Municipal Corporation
 ( Corporate News - 02-Apr-25   19:29 )
  Volumes soar at One 97 Communications Ltd counter
 ( Hot Pursuit - 13-May-25   11:00 )
  Paytm slips after block deal
 ( Hot Pursuit - 13-May-25   11:02 )
  One 97 Communications appoints director
 ( Corporate News - 20-Jan-25   11:43 )
  One97 Communications announces board meeting date
 ( Corporate News - 16-Oct-24   12:47 )
  One 97 Communications Ltd leads losers in 'A' group
 ( Hot Pursuit - 08-Feb-24   15:00 )
  One 97 Communications drops for third day; stock down over 77% from IPO price
 ( Hot Pursuit - 02-Feb-24   13:03 )
  Paytm Q2 net loss narrows to Rs 292 cr
 ( Hot Pursuit - 23-Oct-23   10:28 )
  One 97 Communications allots 67,102 equity shares under ESOP
 ( Corporate News - 06-Feb-24   10:01 )
  One97 Communications to conduct board meeting
 ( Corporate News - 09-Oct-23   09:49 )
Other Stories
  LMW schedules board meeting
  03-Jul-25   09:15
  Julien Agro Infratech announces board meeting date
  03-Jul-25   09:15
  Alembic Pharmaceuticals announces acquisition of Utility Therapeutics
  03-Jul-25   09:15
  Shriram Asset Mgt. Company schedules AGM
  03-Jul-25   09:14
  Ideaforge Technology to convene AGM
  03-Jul-25   09:14
  D-Link (India) to announce Quarterly Result
  03-Jul-25   09:14
  Tuni Textile Mills to conduct board meeting
  03-Jul-25   09:14
  Biocon Biologics receives EU marketing authorisation for Vevzuo® and Evfraxy® biosimilars of Denosumab
  03-Jul-25   09:12
  Shakti Pumps launches QIP issue
  03-Jul-25   09:08
  Jai Mata Glass to conduct board meeting
  02-Jul-25   19:12
Back Top